{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T03:24:49Z","timestamp":1649129089682},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T00:00:00Z","timestamp":1395014400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0091858","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T16:44:37Z","timestamp":1395074677000},"page":"e91858","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Old Habits Die Hard: A Nationwide Utilization Study of Short-Acting Nifedipine in Taiwan"],"prefix":"10.1371","volume":"9","author":[{"given":"Chia-Lin","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Yu","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Ching","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzeng-Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Fang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/01.HYP.0000229653.73128.b6","article-title":"Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States","volume":"48","author":"RS Stafford","year":"2006","journal-title":"Hypertension"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6963-5-21","article-title":"International variation in prescribing antihypertensive drugs: its extent and possible explanations","volume":"5","author":"A Fretheim","year":"2005","journal-title":"BMC Health Serv Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pcad.2004.04.006","article-title":"Calcium antagonists","volume":"47","author":"E Grossman","year":"2004","journal-title":"Prog Cardiovasc Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jama.1991.03470060091033","article-title":"Management of hypertensive crises","volume":"266","author":"RW Gifford Jr","year":"1991","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jama.1995.03530080036038","article-title":"The risk of myocardial infarction associated with antihypertensive drug therapies","volume":"274","author":"BM Psaty","year":"1995","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine. Dose-related increase in mortality in patients with coronary heart disease","volume":"92","author":"CD Furberg","year":"1995","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.1996.03530300007004","article-title":"FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards","volume":"275","author":"C Marwick","year":"1996","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318230201a","article-title":"Short-acting nifedipine and risk of stroke in elderly hypertensive patients","volume":"77","author":"SY Jung","year":"2011","journal-title":"Neurology"},{"key":"ref9","unstructured":"Furmaga EM, Glassman PA, Cunningham FE, Good CB (2005) Reducing the Use of Short-acting Nifedipine by Hypertensives Using a Pharmaceutical Database. In: Henriksen K, Battles JB, Marks ES, Lewin DI, Advances in Patient Safety: From Research to Implementation (Volume 3: Implementation Issues). Rockville (MD)."},{"key":"ref10","unstructured":"Bureau of National Health Insurance, Department of Health, Executive Yuan: The National Health Insurance Statistics, 2011. Available: http:\/\/www.nhi.gov.tw\/English\/webdata\/webdata.aspx?menu=11&menu_id=296&WE_ID=296&webdata_id=4229<\/ext-link>. Accessed 2013 June 26."},{"key":"ref11","first-page":"378","article-title":"Utilization of psychotropic drugs in Taiwan: an overview of outpatient sector in 2000","volume":"65","author":"TP Su","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s002280100349","article-title":"Concomitant prescription of non-steroidal anti-inflammatory drugs and antacids in the outpatient setting of a medical center in taiwan: a prescription database study","volume":"57","author":"JY Liu","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1472-6963-7-26","article-title":"Use frequency of traditional Chinese medicine in Taiwan","volume":"7","author":"FP Chen","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1099-1557(200001\/02)9:1<25::AID-PDS469>3.0.CO;2-E","article-title":"The calcium-channel blocker controversy: historical perspective and important lessons for future pharmacotherapies. An international society of pharmacoepidemiology \u2018hot topic\u2019","volume":"9","author":"JR Kizer","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0828-282X(08)70627-5","article-title":"Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006","volume":"24","author":"BR Hemmelgarn","year":"2008","journal-title":"Can J Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.105.542290","article-title":"Antihypertensive medication use among US adults with hypertension","volume":"113","author":"Q Gu","year":"2006","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/archinte.159.19.2259","article-title":"The use of sublingual nifedipine: a continuing concern","volume":"159","author":"FH Messerli","year":"1999","journal-title":"Arch Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1440-1681.1999.03046.x","article-title":"Sublingual nifedipine in elderly patients: even a low dose induces myocardial ischaemia","volume":"26","author":"Y Ishibashi","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00467-004-1444-x","article-title":"The safety and use of short-acting nifedipine in hospitalized hypertensive children","volume":"19","author":"V Yiu","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s004670200006","article-title":"Evaluation of the safety of short-acting nifedipine in children with hypertension","volume":"17","author":"DW Egger","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1067\/mpd.2001.114699","article-title":"The use of short-acting nifedipine in pediatric patients with hypertension","volume":"139","author":"RT Blaszak","year":"2001","journal-title":"J Pediatr"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"G Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"AV Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"60","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/STROKEAHA.111.637983","article-title":"Emergency department adherence to American Heart Association guidelines for blood pressure management in acute ischemic stroke","volume":"43","author":"EM Grise","year":"2012","journal-title":"Stroke"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1056\/NEJMsa022615","article-title":"The quality of health care delivered to adults in the United States","volume":"348","author":"EA McGlynn","year":"2003","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1099-1557(200001\/02)9:1<11::AID-PDS468>3.0.CO;2-U","article-title":"Nifedipine and mortality risk in the elderly: relevance of drug formulation, dose and duration","volume":"9","author":"CJ Maxwell","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00228-005-0974-x","article-title":"Comparison of information on the pharmacokinetic interactions of Ca antagonists in the package inserts from three countries (Japan, USA and UK)","volume":"61","author":"M Saito","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0895-7061(96)00172-0","article-title":"\u201cInappropriate\u201d physician habits in prescribing oral nifedipine capsules in hospitalized patients","volume":"9","author":"F Rehman","year":"1996","journal-title":"Am J Hypertens"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0091858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:26:10Z","timestamp":1540261570000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0091858"}},"subtitle":[],"editor":[{"given":"Pan-Chyr","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,17]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0091858","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,17]]}}}